Bausch + Lomb Co. Expected to Post Q4 2022 Earnings of $0.23 Per Share (NYSE:BLCO)

Bausch + Lomb Co. (NYSE:BLCOGet Rating) – Research analysts at Jefferies Financial Group decreased their Q4 2022 earnings estimates for shares of Bausch + Lomb in a research report issued on Wednesday, November 2nd. Jefferies Financial Group analyst Z. Weiner now anticipates that the company will post earnings of $0.23 per share for the quarter, down from their previous forecast of $0.29. The consensus estimate for Bausch + Lomb’s current full-year earnings is $1.05 per share. Jefferies Financial Group also issued estimates for Bausch + Lomb’s FY2024 earnings at $1.17 EPS.

Several other equities research analysts have also recently weighed in on BLCO. Royal Bank of Canada reduced their target price on shares of Bausch + Lomb from $18.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday. JPMorgan Chase & Co. lowered their price target on shares of Bausch + Lomb from $16.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday. HC Wainwright lowered their price target on shares of Bausch + Lomb from $21.00 to $20.00 and set a “buy” rating for the company in a report on Thursday. The Goldman Sachs Group reaffirmed a “neutral” rating and issued a $19.00 price objective (down from $22.00) on shares of Bausch + Lomb in a research note on Tuesday, August 30th. Finally, Morgan Stanley reduced their price target on shares of Bausch + Lomb from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Thursday. Four analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $22.54.

Bausch + Lomb Price Performance

Bausch + Lomb stock opened at $14.85 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.10 and a current ratio of 1.57. Bausch + Lomb has a one year low of $12.20 and a one year high of $20.20. The stock’s fifty day simple moving average is $15.59.

Bausch + Lomb (NYSE:BLCOGet Rating) last posted its earnings results on Thursday, August 4th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.20 by $0.09. The business had revenue of $941.00 million for the quarter, compared to analyst estimates of $906.72 million.

Hedge Funds Weigh In On Bausch + Lomb

A number of large investors have recently modified their holdings of BLCO. River Road Asset Management LLC bought a new stake in Bausch + Lomb during the second quarter valued at approximately $2,153,000. Foundry Partners LLC bought a new position in Bausch + Lomb in the second quarter worth about $4,247,000. DekaBank Deutsche Girozentrale purchased a new stake in Bausch + Lomb in the second quarter worth about $1,016,000. Factorial Partners LLC purchased a new stake in shares of Bausch + Lomb during the second quarter valued at approximately $300,000. Finally, TD Asset Management Inc. purchased a new stake in Bausch + Lomb in the second quarter worth approximately $2,852,000. 10.32% of the stock is currently owned by institutional investors.

Bausch + Lomb Company Profile

(Get Rating)

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye.

Featured Articles

Receive News & Ratings for Bausch + Lomb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch + Lomb and related companies with MarketBeat.com's FREE daily email newsletter.